Semi-Annual Consolidated Statement Of Cash Flows

Human Metabolome Technologies, Inc. - Filing #7351674

Concept As at
2023-12-31
2023-07-01 to
2023-12-31
As at
2023-06-30
2022-07-01 to
2022-12-31
As at
2022-12-31
As at
2022-06-30
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-134,873,000 JPY
-90,062,000 JPY
Interest and dividends received
7,000 JPY
7,000 JPY
Interest paid
-1,058,000 JPY
-1,228,000 JPY
Net cash provided by (used in) operating activities
-139,409,000 JPY
-111,565,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-25,587,000 JPY
-8,867,000 JPY
Net cash provided by (used in) investing activities
-26,497,000 JPY
-20,837,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-23,000 JPY
Dividends paid
-58,651,000 JPY
JPY
Net cash provided by (used in) financing activities
-65,838,000 JPY
-6,859,000 JPY
Effect of exchange rate change on cash and cash equivalents
-596,000 JPY
-4,818,000 JPY
Net increase (decrease) in cash and cash equivalents
-232,342,000 JPY
-144,080,000 JPY
Cash and cash equivalents
1,424,447,000 JPY
1,656,789,000 JPY
1,360,663,000 JPY
1,504,744,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.